IMPORTANCE Because hearing loss is highly prevalent and treatable, determining its association with morbidity has major public health implications for disease prevention and the maintenance of health in adults with hearing loss.
H earing health in adults in mid-to-late life is a national priority. 1 More than 50% of US adults 60 years or older have clinically meaningful hearing loss that affects everyday communication, with more than 73 million US adults expected to be affected by 2060. 2, 3 In addition to its high prevalence, hearing loss is also linked to adverse health outcomes. The consistent association of hearing loss with accelerated cognitive decline and incident dementia has been increasingly recognized, 4 and treatment of hearing loss in mid-to-late life could prevent 9% of dementia cases globally. 5 Hearing loss is also independently related to disability, 6, 7 falls, 8 and depressive symptoms. 9 However, the number of studies investigating these associations is limited, and the association between hearing loss and other diseases common in older age has been less well studied. 10 Biological mechanisms of hearing loss have been proposed, particularly in the context of hearing loss and cognition, suggesting that the association between hearing loss and functional outcomes in older adults may be causal. 11 If this association is causal, because hearing loss is prevalent and treatable, understanding the association between hearing and morbidity has major public health implications for disease prevention and health promotion. We used OptumLabs Data Warehouse (OLDW) insurance claims data from US adults (mean [SD] age, 64 [10] years, 48% of participants were women [n = 74 464], 61% were white [n = 93 442]) to test whether an incident hearing loss diagnosis without treatment was associated with new diagnoses for comorbidities related to cognition, geriatric syndromes (eg, falls, fractures), mental health, and cardiovascular and cerebrovascular health over 2 years (n = 154 414 participants), 5 years (n = 44 852 participants), or 10 years (n = 4728 participants) of follow-up.
Methods

Study Population and Observation Periods
The OLDW is a robust, longitudinally linked, database of deidentified individual-level data. Institutional review board approval and patient informed consent were not required because the deidentified data complies with the Health Insurance Portability and Accountability Act Privacy Rule. This retrospective, propensity-matched cohort study used administrative claims data from the OLDW to identify hearing-related products sold or health services rendered from January 1, 2000, to December 31, 2016 . The OLDW includes deidentified claims data for over 125 million privately insured and Medicare Advantage enrollees in a large, private, US health plan from 1993 to the present, representing a diverse population with respect to age, race/ethnicity, and geographic region. The health plan provides comprehensive insurance coverage for physician, hospital, and prescription drug services, including Part D coverage for Medicare Advantage enrollees. The database includes socioeconomic information, including race/ethnicity, household income, and education, for about 73% of enrollees. This information is derived from a nationally recognized supplier of consumer marketing data and is a compilation of public data and derived predictive data. While proprietary, imputation methods for race/ethnicity have been shown in previous studies to have moderate sensitivity (48%), excellent specificity (97%), and moderate positive predictive value (71%) for the purpose of identifying race. 12 The analytic sample was restricted to participants 50 years or older. Three nested samples were created based on data availability for 2-, 5-, and 10-year follow-up periods. For participants with a hearing loss diagnosis, the date of the first hearing loss claim was designated as the index date. For participants with no evidence of hearing loss, the index date was set to a random date of service within the capture window. Observation time was censored at disenrollment. To focus on untreated hearing loss, participants with a hearing loss diagnosis were censored at first evidence of a hearing device claim. Participants were retained in the analytic cohort only if they had continuous enrollment in their health plan for the full length of the follow-up. The resulting samples are nonmutually exclusive; for example, participants who qualified for the 10-year follow-up cohort also qualified for the 2-and 5-year cohorts.
Outcome Variables
Primary outcomes for this study included incident dementia, depression, nonvertebral fractures, accidental falls, acute myocardial infarction, and stroke. Conditions were defined as incident if the participant had no diagnosis (or procedure, if appropriate) code for the condition based on claims during the 12 months prior to the index date. Nonvertebral fractures were defined using International Classification of Disease, 9th Revision, Clinical Modification (ICD-9-CM) (and mapped ICD-10-CM equivalents) and Current Procedural Terminology codes previously used to define these fracture types in a similar database. 13 Accidental falls were identified using external causes of injury codes (ie, E codes) from ICD-9-CM as well as the ICD-10-CM equivalents. New onset of dementia, depression, myocardial infarction, and stroke were identified using code sets and disease identification algorithms provided by the Centers for Medicare and Medicaid Services Chronic Conditions Data
Key Points
Question What is the association between incident hearing loss diagnosis and medical comorbidities in US adults 50 years or older?
Findings In this retrospective, propensity-matched cohort study using administrative claims data, hearing loss was significantly associated with an increased 10-year risk of dementia (3.2 per 100 persons), depression (3.6 per 100 persons), falls (6.9 per 100 persons), and myocardial infarction (1.1 per 100 persons).
Meaning Incident hearing loss is independently related to the risk of other medical diagnoses; mechanisms underlying these associations should be elucidated to determine if hearing loss treatment can reduce risk and maintain health in adults with hearing loss.
Warehouse. 14 These coding algorithms are provided to researchers using administrative claims data and for the specification of data requests for disease-based cohorts. There are algorithms for 62 chronic or disabling conditions that specify diagnosis codes, site of service, and time span. For all conditions, diagnosis codes were allowed on the primary or any secondary position on the claim.
Hearing Loss Diagnosis
Hearing loss was determined by the presence of at least 2 claims separated by no more than 730 days with an ICD-9-CM diagnosis code for hearing loss (V41. Because the exposure of interest is age-related hearing loss, participants were excluded if they had evidence of hearing loss secondary to correctable medical conditions (ie, via surgical measures) or hearing loss fundamentally different from typical peripheral age-related hearing loss (ie, central pathology), including sudden hearing loss (ICD-9-CM code, 388.2), hyperacusis (ICD-9-CM code, 388.42), acoustic nerve disorders (ICD-9-CM code, 388.5), otorrhea (ICD-9-CM code, 388.6x), otalgia (ICD-9-CM code, 388.7x), conductive hearing loss (ICD-9-CM code, 389.0x), neural hearing loss (ICD-9-CM code, 389.12), and/or central hearing loss (ICD-9-CM code, 389.14).
Statistical Analysis
Because of suspected underlying differences in participants with and without hearing loss, matched cohorts were created for each of the 3 follow-up periods using a 2-stage process. First, participants with uncorrected hearing loss were block-matched to persons with no evidence of hearing loss on the basis of follow-up time, insurance type (commercial or Medicare Advantage), and cost deciles. Subsequently, nearest-neighbor 1:1 caliper-based greedy propensity score matching without replacement was used, with the following variables measured during the 1 year prior to the index date included in the propensity model: age, 2 sex, census region, net worth, race/ethnicity, education level, health care utilization, Charlson Comorbidity Index, 15 number of office visits (natural log transformed, both linear and quadratic terms), number of inpatient stays, inpatient length of stay, number of emergency department visits, dementia, mild cognitive impairment, depression, stoke, myocardial infarction, coronary artery disease, breast cancer, prostate cancer, renal cell carcinoma, colorectal cancer, and baseline medical costs (evidence of any costs and total medical costs). Block matching within cost deciles was required during the first stage owing to the skewed nature of cost, which can result in poorly matched cost distributions. Within each block, caliper matching was used to match cases to the closest control with a propensity score within 0.2 SDs. Participants not matched were excluded from analysis. The quality of the matched groups was assessed using absolute standardized differences. After matching, no variable exhibited an absolute standardized difference of more than 10%, indicating that persons with and without hearing loss were balanced on baseline variables as well as follow-up time (eFigure in the Supplement).
To describe baseline characteristics, categorical variables were reported as frequencies and percentages. Univariate comparisons were conducted according to the distribution of the data, using t tests, χ 2 tests, and Mann-Whitney U tests when appropriate. Statistical significance was assessed at the 2-sided 5% level. Multivariable analysis was conducted on the matched cohorts to evaluate the risk of incident comorbid conditions associated with hearing loss. Relative risks (RRs) and risk differences with 95% CIs were modeled using a modified Poisson regression with robust standard errors. 16 Analysis was limited to incident cases and adjusted for the following baseline variables: age, sex, race/ethnicity, census region, net worth, Charlson Comorbidity Index, coronary artery disease, medical costs (log transformed), number of inpatient stays, inpatient length of stay, number of emergency department visits, and number of office visits. Models for a given comorbidity were adjusted for other disease outcomes. Analytic files were created using SAS software, version 9.4 (SAS Institute). Analyses were performed using R 3.3.2 (R Core Team, 2016), including R packages ggplot2, data.table, tableone, Rcpp, Zelig, attribrisk, lmtest, sandwich, modmarg, car, ggfortify, and survival; additional R code was custom created. Matching was done in C++ and R; the code is original and was written by author A.D.K.
Results
Postmatching, 48% of participants were women (n = 74 464), 61% were white (n = 93 442), 81% had completed some college or more (n = 124 749), and 31% were Medicare Advantage insured (n = 48 056), with a mean (SD) age of 64 (10) years in the 2-year cohort; results were similar in the 5-and 10-year cohorts (Table) . At baseline, 3% of the participants in the 2-year cohort had ICD-9-CM codes for dementia (n = 4293), 3% had codes for stroke (n = 3916), 11% had codes for depression (n = 16 683 ), and fewer than 1% had codes for acute myocardial infarction (n = 625; Table) . At baseline, 1% of participants in the 10-year cohort had ICD-9-CM codes for dementia (n = 32), 1% had codes for stroke (n = 65), and 8% had codes for depression (n = 393). Consistent with successful matching, no clinical differences in baseline covariates were observed between the incident hearing loss and the no hearing loss groups in all 3 cohorts (Table) .
In analysis adjusted for demographics, health care utilization, and comorbidities, hearing loss diagnosis (vs no evidence of hearing loss) was associated with a 20% to 50% increased risk of all outcomes, excluding fracture at 10 years (RR, 1.15; 95% CI, 0.90-1.48) and myocardial infarction at 5 years (RR, 1.05; 95% CI, 0.92-1.21). Associations were strongest for dementia (RR at 5 years, 1.50; 95% CI, 1.38-1.64) and depression (RR at 5 years, 1.41; 95% CI, 1.26-1.58; Figure 1 ).
The estimate of the absolute risk for all outcomes was statistically significantly greater in persons with hearing loss than in those without hearing loss for all follow-up Adjusted for age, sex, race/ethnicity, census region, net worth, Charlson Comorbidity Index, coronary artery disease, medical costs (log transformed), number of inpatient stays, inpatient length of stay, number of emergency department visits and number of office visits. Models for a given comorbid outcome were also adjusted for other disease outcomes; for example, models estimating the association between hearing loss and dementia were also adjusted for depression, acute myocardial infarction, and stroke. RR indicates relative risk. Models for a given comorbid outcome were also adjusted for other disease outcomes; for example, models estimating the association between hearing loss and dementia were also adjusted for depression, acute myocardial infarction, and stroke.
for myocardial infarction, and 2.69 per 100 persons (95% CI, 1.03-4.35) for stroke ( Figure 2 ).
Discussion
In this large observational study using administrative claims data with up to 10 years of follow-up, incident hearing loss (vs no evidence of hearing loss) was independently associated with greater incident morbidity across a range of health conditions in adults 50 years or older. The greatest relative increase in risk was estimated for dementia and depression, with hearing loss associated with an approximately 50% increase in both conditions over 5 years. The absolute risk of comorbid conditions associated with hearing loss increased with longer follow-up time, with the greatest risk estimated for depression followed by falls and dementia in the cohort observed for 10 years. It is perhaps not surprising that the greatest RRs were estimated for those in the 5-year cohort, but the greatest risk differences were in the 10-year cohort. Although the strength of a risk factor-outcome association may diminish over the course of life, the absolute risk associated with that risk factor may still increase with advancing age. 17 In contrast to relative measures of association, which give insight into etiologic associations, absolute measures have relevance for public health planning because they are interpreted as the risk of morbidity in persons with hearing loss that could be prevented with hearing loss treatment or prevention, although this interpretation assumes a causal association. Our results are consistent with a growing body of literature linking hearing loss to adverse health outcomes in older adults. Recent meta-analyses have reported that hearing loss is associated with a 2-fold increase in risk for dementia 5, 18 and cognitive impairment 19 and a 70% to 80% increase in the risk of falls. 8 Clinically, hearing loss is recognized as contributing to poorer quality of life 20 and depression, 21 and hearing loss treatment may result in an improvement in self-reported depressive symptoms. 22 Few studies have investigated hearing loss as a possible risk factor for other comorbid conditions. 23 Using data from the National Health Interview Survey, McKee and colleagues 10 found that hearing loss was crosssectionally associated with several medical conditions after adjustment for demographic and clinical covariates, including a 39% increase in the prevalence of stroke. Our study adds to the literature with its large sample size and up to 10 years of longitudinal follow-up. Causal mechanistic pathways have been hypothesized to underlie the estimated associations. For dementia in particular, possible mechanisms could include the influence of distorted peripheral encoding of sound on cognitive load and changes in brain structure and/or function. 11 Reduced awareness of the auditory environment could potentially increase the risk of falls. 24 Additionally, hearing loss could be related to frailty 25 or lead to reduced social engagement, which in turn could increase the risk for disease. 11, 26, 27 Alternatively, the observed associations could be the result of underlying processes or factors that are related both to hearing loss and to the adverse outcomes (eg, microvascular disease, inflammation). 11, 28 In this study, hearing loss was associated with increased risk of both myocardial infarction and stroke, although the magnitude of the risk estimated for these outcomes was less than that for dementia and depression. These results could be indicative of a common cause leading to both hearing loss and all outcomes that have vascular contributors, including dementia. In support of this hypothesis, vascular factors and markers, including hypertension, 29, 30 elevated glycosylated hemoglobin levels, 31 obesity, [31] [32] [33] and subclinical atherosclerosis, 34 have been shown to be related to a small increase in risk of hearing impairment. Hearing loss also could increase the risk of vascular outcomes through the causal mechanisms previously described, particularly increased social isolation. Increased social isolation is consistently related to all-cause mortality and cardiovascular disease in observational studies. 35, 36 Importantly, the possible mechanisms relating hearing loss to comorbid outcomes are not mutually exclusive. Estimates from observational studies with inadequate adjustment for vascular markers that are unmeasured or measured with error could represent both a true causal effect as well as the confounding effect of underlying vascular disease. Although a strength of our study is the use of propensity score matching to adjust for confounding, variables included in that matching were limited to those covariates that were available, and this study relies on administrative claims diagnosis codes that are generated for the purpose of billing and payment, not for research. As an observational study, it is likely that unmeasured and residual confounding exists, highlighting the need for experimental studies of the influence of hearing loss treatment on these outcomes.
Limitations
While it provides large sample sizes and longitudinal patient histories, the use of claims data for research can present challenges. 37 There are limitations to the ability to identify all cases of conditions, such as hearing loss, that do not necessarily drive reimbursement. Although we attempted to maximize specificity with our definition of uncorrected hearing loss, it is likely that hearing loss is not fully captured in the claims data, particularly mild hearing loss, or that it is documented in claims only when it is severe enough to require treatment or if a patient's health plan covers services. However, the inclusion of persons with hearing loss in our unexposed group would result in a conservative estimate of the association between hearing loss and comorbidities. It is also possible that our findings could be the result of a detection bias, in which participants who seek diagnosis for hearing loss may have a more frequent interaction with the health care system, and therefore are more likely to have claims for comorbidities. Replication of these findings in population-based studies will be important to help address this potential bias. Although our data are from a large, geographically diverse database, the study population is mostly white and wealthier than the general US population; this lack of representativeness could affect the generalizability of our findings if the factors by which our study population differs from the general population modify the as-sociation between hearing loss and comorbid conditions. If the association between hearing loss and dementia, for example, is stronger in persons of lower socioeconomic status or in those who are not white, then our results would underestimate that association and our findings are not generalizable. Additionally, accurate mortality information is not available in the data source used for this project, and so we were unable to take the competing risk of death into account into our analyses. Because absolute risk of an outcome over time is dependent on the survival function both for the outcome and for death, failure to account for competing risks may lead to biased estimates of the cumulative incidence.
38
In our study, individual hearing loss morbidity analyses were adjusted for all other conditions to estimate the association between hearing loss and a specific condition independent of other comorbidities. For example, the estimated association between hearing loss and dementia was adjusted for depression. However, we documented that hearing loss is strongly related to depression in this cohort, and depression is a known risk factor for dementia. 5 If hearing loss leads to depression, and depression in turn leads to dementia (ie, depression is a mediator of the association between hearing loss and dementia), then adjustment for depression may have attenuated the estimated association between hearing loss and dementia in our study. However, even after this conservative adjustment, we documented an excess of 3 dementia diagnoses attributable to hearing loss per 100 persons over 10 years.
Conclusions
In this large observational study using administrative claims data, we found that incident hearing loss diagnosis (vs no evidence of hearing loss) was independently associated with greater incident morbidity across a range of health conditions, including dementia, depression, falls, and cardiovascular disease. Future studies are needed to elucidate the mechanisms underlying these associations and to determine if hearing loss treatment could reduce risk and maintain health in middleaged and older adults.
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